Article
L'RRK de Triomphe: a solution for LRRK2 GTPase activity?
Biochemical Society transactions - 15 Dec 2016
Nixon-Abell Jonathon, Berwick Daniel C, Harvey Kirsten
Abstract excerpt
Leucine-rich repeat kinase 2 (LRRK2) is a central protein in the pathogenesis of Parkinson's disease (PD), yet its normal function has proved stubbornly hard to elucidate. Even though it remains unclear how pathogenic mutations affect LRRK2 to cause PD, recent findings provide increasing cause for optimism. We summarise here the developing consensus over the effect of pathogenic mutations in the Ras of complex...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
